Aspirin
1 is a non-steroidal antiinflammatory drug that and act as an anticoagulant. Tablets containing 75 mg of exhibits antiinflammatory, analgesic and antipyretic each of aspirin and clopidogrel are available in market. activities. Clopidogrel 1 is a platelet aggregation inhibitor Reported methods for the determination of aspirin and clopidogrel are spectrofluorimetry tablets. This paper aims to report a simple, accurate and The chromatographic conditions were optimized to achieve reliable and reproducible resolution (Table 1) . A stock solution of aspirin and clopidogrel was prepared by Twenty tablets each containing 75 mg of aspirin and 75 mg of clopidogrel (Clopid-AS, Genx Pharma) were weighed and powdered. A quantity of powder equivalent to 10 mg each of aspirin and clopidogrel was transferred in to a 50 ml standard flask and dissolved in methanol.
The volume was made up to 50 ml with methanol. One millilitre of this solution was pipetted in to a 50 ml volumetric flask containing 1 ml of nimesulide (1000 µg/ ml). The solution was filtered using 0.2 µ membrane filter and the filtrate is referred to as formulation solution. Twenty microliters of the standard and formulation solutions were injected onto the column and the 2.0, 2.7, 5.9 min, respectively.
A calibration graph was plotted using peak area ratio of the aspirin and clopidogrel to that of internal standard vs. concentration of the standard solutions. The calibration graph was found to be linear in the range of 1 to 5 µg/ ml for both aspirin and clopidogrel. The slope, intercept and correlation values are shown in Table 2 .
The system suitability procedures as precision, accuracy, LOD, LOQ, number of theoretical plates and tailing factor were determined (Table 2 ). Precision at the method was studied by repeatedly injecting the mixture of aspirin and clopidogrel. To study the reliability and accuracy of the 
